Igeahub.com - Top Pharma News - Luca Dezzani

Pharma 2016: One Year in Review

Lots of new things happened in the pharmaceutical industry in 2016. At igeahub.com, our mission is to make the pharmaceutical world simple and clear to everyone. We want our readers to have a privileged view on the key player in the healthcare system, and we do our best to keep things simple but highly accurate. The … Continue reading Pharma 2016: One Year in Review

Advertisements
Igeahub.com - Top Pharma News - Luca Dezzani

Top Pharma News – August 2016

Pfizer Acquires Bamboo Therapeutics and Aims to Become Industry Leader in Gene Therapy August 1, 2016 Pfizer Inc. has announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C. Bamboo Therapeutics focused on developing gene therapies for treating patients with certain rare diseases related to neuromuscular conditions … Continue reading Top Pharma News – August 2016

GSK and Verily Agree to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines

01 August 2016 GSK has announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences) to form Galvani Bioelectronics in order to enable the research, development and commercialisation of bioelectronic medicines. In the new jointly owned company, GSK will hold a 55% equity interest and Verily will hold 45%. Galvani Bioelectronics will be … Continue reading GSK and Verily Agree to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines

Igeahub.com - Top Pharma News - Luca Dezzani

Pharma Oncology | Top News – Spring 2016

GSK Returns to War against Cancer April 3, 2016 It looked like the UK pharmaceuticals group GlaxoSmithKline (GSK) was declaring surrender in the war on cancer when the company agreed to sell its oncology drugs for $16 billion to Novartis in 2014. However, after two years, GSK returns to this war on cancer again.   … Continue reading Pharma Oncology | Top News – Spring 2016

Igeahub.com - Top Pharma News - Luca Dezzani

Top Pharma News – May 2016

Taltz® (ixekizumab) Now Available in the U.S. for Treating Plaque Psoriasis May 2, 2016 Eli Lilly and Company has announced that Taltz® (ixekizumab) injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis is now available in the United States by prescription order through a contracted network of specialty pharmacies. Patient support programs are also offered by Lilly … Continue reading Top Pharma News – May 2016

StrimvelisTM receives European marketing authorisation to treat ADA-SCID

27 May 2016 GlaxoSmithKline (GSK), Ospedale San Raffaele (OSR), and Fondazione Telethon (Telethon) have announced that the European Commission has approved Strimvelis, the first ex-vivo stem cell gene therapy for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency). A child born with ADA-SCID does … Continue reading StrimvelisTM receives European marketing authorisation to treat ADA-SCID

Novartis logo - luca dezzani

Novartis Separates its Pharmaceuticals Division into two business units: Novartis Oncology and Novartis Pharmaceuticals

May 17, 2016 Novartis has announced that it has created two business units reporting to the CEO: Novartis Oncology and Novartis Pharmaceuticals. The Innovative Medicines Division at Novartis will be formed by these business units. The Executive Committee of Novartis (ECN) will be effective from July 1, 2016, and the leader of each business will … Continue reading Novartis Separates its Pharmaceuticals Division into two business units: Novartis Oncology and Novartis Pharmaceuticals

M&A in Pharma Igea Luca Dezzani

M&A in Pharma: Best 10 Deals in 2015-16

Merger and acquisitions in the pharmaceutical industry have been thought to bring significant impact to the current health care system, particularly in developing complex breakthrough medicines that could effectively treat a wide range of debilitating health conditions including cancer and improve health outcomes. According to PricewaterhouseCoopers’ (PwC’s) Health Research Institute, merger mania will be one … Continue reading M&A in Pharma: Best 10 Deals in 2015-16

Top 10 Pharmas 2016 Igea Luca Dezzani

Top 10 Pharmaceutical Companies 2016

Top 10 Pharmaceutical Companies 2017 is Now Available The global prescription pharmaceuticals market was estimated to be USD 1,114 billion in 2015. The market is mature and highly consolidated. The top-10 pharmaceutical companies in this market had share of over 30% in 2015. These companies are large and established organizations that are primarily located in … Continue reading Top 10 Pharmaceutical Companies 2016

Igeahub.com - Top Pharma News - Luca Dezzani

Top Pharma News – April 2016

AbbVie Agrees to Buy Stemcentrx April 28, 2016 Pharmaceutical company AbbVie Inc. has agreed to acquire Stemcentrx Inc., a cancer-drug developer, for $5.8 billion. This is part of AbbVie’s continuing aggressive push for building an oncology business. Keytruda Shows Promise in Patients with Merkel Cell Carcinoma, A Rare Form of Skin Cancer April 19, 2016 … Continue reading Top Pharma News – April 2016